Charts

Orphazyme A/S(NASDAQ: ORPH) hasdecided to withdraw its European Marketing Application for arimoclomolfor Niemann-Pick ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips After Orphazyme announced that it would withdraw the application for approval of its drug and delist its ADSs, ORPH stock is falling. The post Dear ORPH Stock Fans, Mark Your Calendars for March 31 appeared first on InvestorPlace. More From InvestorPlace Get in Now on Tiny $3 ‘Forever Battery’ Stock It doesn’t matter if you have $500 in savings or $5 million. Do this now. Stock Prodigy Who Found NIO at $2… Says Buy THIS Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Keytruda ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Grab your cup of coffee, investor! We're starting off the day with a dive into the biggest pre-market stock movers for Tuesday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday appeared first on InvestorPlace. More From InvestorPlace Get in Now on Tiny $3 ‘Forever Battery’ Stock It doesn’t matter if you have $500 in savings or $5 million. Do this now. Stock Prodigy Who Found NIO at $2… Says Buy THIS Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”

Gainers Smart for Life, Inc. (NASDAQ: SMFL) rose 75.3% to $1.63 in pre-market trading. Smart For Life recently said it is ...

Gainers Allarity Therapeutics (NASDAQ:ALLR) stock rose 25.3% to $2.84 during Monday's after-market session. The market value of their ...

Gainers Kidpik Corp. (NASDAQ: PIK) shares surged 158.2% to settle at $4.75 on Thursday after the company announced a partnership ...

Gainers TD Holdings, Inc. (NASDAQ: GLG) rose 83.2% to $0.4348 after the company reported FY21 results. Allego N.V. (NASDAQ: ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Occidental Petroleum (OXY) stock is rising higher on Thursday following news that Berkshire Hathaway increased its stake in the company. The post Why Is OXY Stock Up Today? Does Warren Buffett’s Berkshire Want to Buy Occidental Petroleum? appeared first on InvestorPlace. More From InvestorPlace Get in Now on Tiny $3 ‘Forever Battery’ Stock It doesn’t matter if you have $500 in savings or $5 million. Do this now. Stock Prodigy Who Found NIO at $2… Says Buy THIS Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”

InvestorPlace - Stock Market News, Stock Advice & Trading Tips The troubled biotech company's share price is up 40% despite plans to delist from the Nasdaq exchange and lay off 50% of its workers. The post Why Is Orphazyme (ORPH) Stock Up Today? appeared first on InvestorPlace. More From InvestorPlace Get in Now on Tiny $3 ‘Forever Battery’ Stock It doesn’t matter if you have $500 in savings or $5 million. Do this now. Stock Prodigy Who Found NIO at $2… Says Buy THIS Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”

Gainers TC BioPharm (Holdings) (NASDAQ:TCBP) shares rose 31.0% to $1.31 during Thursday's pre-market session. The ...

Gainers TD Holdings, Inc. (NASDAQ: GLG) rose 81.2% to $0.43 in pre-market trading after the company reported FY21 ...

Gainers Marygold Companies (NYSE: MGLD) shares surged 89.4% to close at $4.11 on Friday after dropping 21% on Thursday. TeraWulf ...

U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq dropping 150 points on Friday. The Dow traded up 0.07% to ...

During Friday's session, 198 companies made new 52-week lows. Key Facts About Today's 52-Week Highs And ...

Gainers Clearside Biomedical (NASDAQ:CLSD) shares increased by 35.2% to $1.82 during Friday's regular session. ...

U.S. stocks traded mixed midway through trading, with the Nasdaq dropping around 100 points on Friday. The Dow traded up 0.49% to ...

Gainers Marygold Companies (NYSE: MGLD) jumped 189.4% to $6.28 after dropping 21% on Thursday. Altamira Therapeutics Ltd. ...

Orphazyme A/S's(NASDAQ: ORPH) board of directors has called for a court-mediated restructuring, prompting thesecond ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, traders! We're starting the final day of the workweek with a look at the biggest pre-market stock movers for Friday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday appeared first on InvestorPlace. More From InvestorPlace Get in Now on Tiny $3 ‘Forever Battery’ Stock It doesn’t matter if you have $500 in savings or $5 million. Do this now. Stock Prodigy Who Found NIO at $2… Says Buy THIS Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”

Gainers Excellon Resources Inc. (NYSE: EXN) rose 133.7% to $2.29 in pre-market trading after jumping around 13% on ...

Benzinga's “After-Hours Movers & News” highlights the biggest movers of the day. The information on the price action ...

Gainers Clearside Biomedical (NASDAQ:CLSD) stock moved upwards by 14.8% to $1.55 during Thursday's after-market session. The ...

Gainers Cyren Ltd. (NASDAQ: CYRN) shares surged 118.9% to settle at $4.75 on Thursday. Cyren recently announced a $12 million ...

U.S. stocks pared some earlier lossestoward the end trading, with the Nasdaq jumping 2% on Thursday. US President Biden, during ...

Gainers Lantheus Holdings (NASDAQ:LNTH) stock rose 33.3% to $38.46 during Thursday's regular session. The current ...

U.S. stocks remained lower midway through trading on Thursday after Russia’s President Vladimir Putin announced that the ...

Gainers Indonesia Energy Corporation Limited (NYSE: INDO) shares climbed 66.7% to $12.55 following a 16% surge on ...

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Appoints COO David ...

CytRx Corporation (OTCQB: CYTR) (“CytRx” or the “Company”), a biopharmaceutical company focused on research and development for the oncology and neurodegenerative disease categories, today commented on Orphazyme A/S's (NASDAQ: ORPH) ("Orphazyme") announced update on the ongoing review of the Marketing Authorisation Application for its investigational product candidate, arimoclomol, for the treatment of Niemann-Pick disease type C ("NPC") by the Committee for Medicinal Products for Human Use ("CHMP") of the European Medicines Agency ("EMA"). CytRx licensed arimoclomol to Orphazyme in exchange for milestone payments and royalties.

Orphazyme A/S(NASDAQ: ORPH) has been notified by the Committee for Medicinal Products for Human Use (CHMP) of anegative ...

Gainers Imperial Petroleum Inc.(NASDAQ: IMPP) rose 45.1% to $1.64 in pre-market trading after gaining around 41% on ...

Gainers Biofrontera (NASDAQ:BFRA) stock moved upwards by 11.8% to $3.49 during Friday's pre-market session. The ...

Investors in Orphazyme A/S (ORPH) saw new options become available this week, for the July 15th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 151 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration..

CytRx Corporation (OTCQB: CYTR) (“CytRx” or the “Company”), a biopharmaceutical company focused on research and development for the oncology and neurodegenerative disease categories, today highlighted Orphazyme A/S's (NASDAQ: ORPH) ("Orphazyme") announced update on the process and anticipated timelines for resubmission of its New Drug Application ("NDA") to the U.S. Food and Drug Administration ("FDA") for its investigational product candidate, arimoclomol, for the treatment of Niemann-Pick disease type C ("NPC"). CytRx licensed arimoclomol to Orphazyme in exchange for milestone payments and royalties.

Gainers Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) surged 26% to close at $2.24. Y-mAbs reported completion of pre-BLA meeting with ...

The Nasdaq turned lower during the mid-day session, with the tech-laden index falling 100 points on Friday. Midway through trading ...

Gainers Modular Medical, Inc. (NASDAQ: MODD) shares climbed 34.5% to $4.99 following its recent uplisting to the Nasdaq Capital ...

Gainers Modular Medical Inc(NASDAQ: MODD) rose 321% to $15.64 in pre-market trading. Modular Medical, on Thursday, ...

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Orphazyme Preannounces ...

Gainers Zogenix, Inc. (NASDAQ: ZGNX) shares rose 56.1% to $24.41 in pre-market trading after UCB announced plans to acquire the ...

Orphazyme A/S(NASDAQ: ORPH)expects FY21 sales of DKK 35 million – DKK 37 million, compared to the previous guidance of ...

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus FDA Committee Votes Against ...

CytRx Corporation (OTCQB:CYTR) (“CytRx” or the “Company”), a specialized biopharmaceutical company focused on research and development for the oncology and neurodegenerative disease categories, today commented on its results for the quarter ended September 30, 2021. In addition, CytRx recapped corporate developments as well as matters pertaining to its agreements with ImmunityBio, Inc. (NASDAQ: IBRX) (“ImmunityBio”) and Orphazyme A/S (NASDAQ:ORPH) ("Orphazyme"). The Company’s 10-Q was filed today.

CytRx Corporation (OTCQB: CYTR) (“CytRx” or the “Company”), a specialized biopharmaceutical company focused on research and development for the oncology and neurodegenerative disease categories, today commented on Orphazyme A/S's (NASDAQ: ORPH) ("Orphazyme") encouraging regulatory update following its recently held Type A meeting with the U.S. Food and Drug Administration ("FDA") on arimoclomol, a heat shock protein amplifier intended for the treatment of Niemann-Pick disease Type C (“NPC”). Arimoclomol, CytRx's drug candidate, was sold to Orphazyme in exchange for milestone payments and royalties.

Gainers ABVC BioPharma, Inc. (NASDAQ: ABVC) shares jumped 250% to $8.91 on abnormally-high volume. The stock is seeing increased ...

Orphazyme A/S(NASDAQ: ORPH) shares are moving higher afterproviding a regulatory updatefor arimoclomol in ...